Usually a death sentence, extensively drug-resistant tuberculosis (XDR-TB) can potentially be cured with a new drug combination.
by Amy Green
Health ENews, February 16, 2017
Interim results from the Nix-TB trial, which were presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle, are extremely promising and point to new hope for people diagnosed with XDR-TB. According to the TB Alliance, the organisation conducting the trial, the “vast majority” of patients with XDR-TB in the study were “clinically well” and “able to go home to their families” after completing just six months of treatment with a new drug regimen (bedaquiline and pretomanid together with linezolid).